BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 34508644)

  • 1. A molecularly integrated grade for meningioma.
    Driver J; Hoffman SE; Tavakol S; Woodward E; Maury EA; Bhave V; Greenwald NF; Nassiri F; Aldape K; Zadeh G; Choudhury A; Vasudevan HN; Magill ST; Raleigh DR; Abedalthagafi M; Aizer AA; Alexander BM; Ligon KL; Reardon DA; Wen PY; Al-Mefty O; Ligon AH; Dubuc AM; Beroukhim R; Claus EB; Dunn IF; Santagata S; Bi WL
    Neuro Oncol; 2022 May; 24(5):796-808. PubMed ID: 34508644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomic analysis of spinal meningiomas: correlation with histopathological grade.
    Driver J; Santagata S; Bi WL; Chi JH
    J Neurosurg Spine; 2023 Dec; 39(6):729-733. PubMed ID: 37728381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis.
    Sahm F; Schrimpf D; Stichel D; Jones DTW; Hielscher T; Schefzyk S; Okonechnikov K; Koelsche C; Reuss DE; Capper D; Sturm D; Wirsching HG; Berghoff AS; Baumgarten P; Kratz A; Huang K; Wefers AK; Hovestadt V; Sill M; Ellis HP; Kurian KM; Okuducu AF; Jungk C; Drueschler K; Schick M; Bewerunge-Hudler M; Mawrin C; Seiz-Rosenhagen M; Ketter R; Simon M; Westphal M; Lamszus K; Becker A; Koch A; Schittenhelm J; Rushing EJ; Collins VP; Brehmer S; Chavez L; Platten M; Hänggi D; Unterberg A; Paulus W; Wick W; Pfister SM; Mittelbronn M; Preusser M; Herold-Mende C; Weller M; von Deimling A
    Lancet Oncol; 2017 May; 18(5):682-694. PubMed ID: 28314689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relevance of Simpson grading system and recurrence-free survival after surgery for World Health Organization Grade I meningioma.
    Nanda A; Bir SC; Maiti TK; Konar SK; Missios S; Guthikonda B
    J Neurosurg; 2017 Jan; 126(1):201-211. PubMed ID: 27058201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The correlation of clinical and chromosomal alterations of benign meningiomas and their recurrences.
    Och W; Szmuda T; Kulbacki K; Witek K; Sikorska B; Zakrzewska M; Springer J; Reszeć J; Parda A; Liberski PP
    Neurol Neurochir Pol; 2016; 50(6):395-402. PubMed ID: 27480481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular biological determinations of meningioma progression and recurrence.
    Linsler S; Kraemer D; Driess C; Oertel J; Kammers K; Rahnenführer J; Ketter R; Urbschat S
    PLoS One; 2014; 9(4):e94987. PubMed ID: 24722350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Necrosis is a consistent factor to recurrence of meningiomas: should it be a stand-alone grading criterion for grade II meningioma?
    Góes P; Santos BFO; Suzuki FS; Salles D; Stávale JN; Cavalheiro S; de Paiva Neto MA
    J Neurooncol; 2018 Apr; 137(2):331-336. PubMed ID: 29270884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. World Health Organization Grade II Meningiomas: The Role of Adjuvant/Salvage Gamma Knife Surgery After Initial Surgery and Prognostic Factor Assessment.
    Liu X; Shan B; Wang M; Xu J
    World Neurosurg; 2018 Jan; 109():e352-e362. PubMed ID: 28987849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical implications of DNA methylation-based integrated classification of histologically defined grade 2 meningiomas.
    Ehret F; Perez E; Teichmann D; Meier S; Geiler C; Cosmas Z; Franke H; Roohani S; Wasilewksi D; Onken J; Vajkoczy P; Schweizer L; Kaul D; Capper D
    Acta Neuropathol Commun; 2024 May; 12(1):74. PubMed ID: 38720399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Relevance of Simpson Grade Resections in Modern Neurosurgical Treatment of World Health Organization Grade I, II, and III Meningiomas.
    Ehresman JS; Garzon-Muvdi T; Rogers D; Lim M; Gallia GL; Weingart J; Brem H; Bettegowda C; Chaichana KL
    World Neurosurg; 2018 Jan; 109():e588-e593. PubMed ID: 29042332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. World Health Organization Grade I Convexity Meningiomas: Study on Outcomes, Complications and Recurrence Rates.
    Nanda A; Bir SC; Konar S; Maiti TK; Bollam P
    World Neurosurg; 2016 May; 89():620-627.e2. PubMed ID: 26704204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. WHO grade and pathological markers of meningiomas: Clinical and prognostic role.
    Franca RA; Della Monica R; Corvino S; Chiariotti L; Del Basso De Caro M
    Pathol Res Pract; 2023 Mar; 243():154340. PubMed ID: 36738518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of the Extent of Resection in Modern Neurosurgical Practice of World Health Organization Grade I Meningiomas.
    Winther TL; Torp SH
    World Neurosurg; 2017 Mar; 99():104-110. PubMed ID: 27867123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between laminin γ1 expression and meningioma grade, recurrence, and progression-free survival.
    Ke HL; Ke RH; Li B; Wang XH; Wang YN; Wang XQ
    Acta Neurochir (Wien); 2013 Jan; 155(1):165-71. PubMed ID: 23053286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extent of resection and survival outcomes in World Health Organization grade II meningiomas.
    Soni P; Davison MA; Shao J; Momin A; Lopez D; Angelov L; Barnett GH; Lee JH; Mohammadi AM; Kshettry VR; Recinos PF
    J Neurooncol; 2021 Jan; 151(2):173-179. PubMed ID: 33205354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical features and treatment of World Health Organization grade II and III meningiomas in childhood: report of 23 cases.
    Wang XQ; Jiang CC; Zhao L; Gong Y; Hu J; Chen H
    J Neurosurg Pediatr; 2012 Nov; 10(5):423-33. PubMed ID: 22938082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of 1p and 14q status, MIB-1 labeling index and progesterone receptor immunoexpression in meningiomas: Adjuncts to histopathological grading and predictors of aggressive behavior.
    Kumar S; Kakkar A; Suri V; Kumar A; Bhagat U; Sharma MC; Singh M; Suri A; Sarkar C
    Neurol India; 2014; 62(4):376-82. PubMed ID: 25237942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA microarray analysis identifies CKS2 and LEPR as potential markers of meningioma recurrence.
    Menghi F; Orzan FN; Eoli M; Farinotti M; Maderna E; Pisati F; Bianchessi D; Valletta L; Lodrini S; Galli G; Anghileri E; Pellegatta S; Pollo B; Finocchiaro G
    Oncologist; 2011; 16(10):1440-50. PubMed ID: 21948653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic changes with prognostic value in histologically benign meningiomas.
    Barbera S; San Miguel T; Gil-Benso R; Muñoz-Hidalgo L; Roldan P; Gonzalez-Darder J; Cerda-Nicolas M; Lopez-Gines C
    Clin Neuropathol; 2013; 32(4):311-7. PubMed ID: 23442303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resected WHO grade I meningioma and predictors of local control.
    Nowak-Choi K; Palmer JD; Casey J; Chitale A; Kalchman I; Buss E; Keith SW; Hegarty SE; Curtis M; Solomides C; Shi W; Judy K; Andrews DW; Farrell C; Werner-Wasik M
    J Neurooncol; 2021 Mar; 152(1):145-151. PubMed ID: 33420897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.